← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2010Last known activity
Jun 30, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 6 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT06103409Overall official - principal investigatorPhase 1/Phase 2Jun 30, 2021
- NCT06103409Lead sponsorPhase 1/Phase 2Jun 30, 2021
- NCT06103409Sponsor investigatorPhase 1/Phase 2Jun 30, 2021
- NCT06103409OfficialPhase 1/Phase 2Jun 30, 2021
- NCT06103409Reponsible party - principal investigatorPhase 1/Phase 2Jun 30, 2021
- NCT05445089Lead sponsorPhase 2/Phase 3Aug 1, 2020
- NCT05445089Reponsible party - principal investigatorPhase 2/Phase 3Aug 1, 2020
- NCT04545307Reponsible party - principal investigatorPhase 2/Phase 3Nov 27, 2019
- NCT04545307CollaboratorPhase 2/Phase 3Nov 27, 2019
- NCT05975892Lead sponsorPhase 1/Phase 2Aug 30, 2018
- NCT05975892Reponsible party - principal investigatorPhase 1/Phase 2Aug 30, 2018
- NCT05975892Overall official - principal investigatorPhase 1/Phase 2Aug 30, 2018
- NCT06103396Reponsible party - principal investigatorPhase 1/Phase 2Jan 30, 2018
- NCT06103396OfficialPhase 1/Phase 2Jan 30, 2018
- NCT06103396Study chairPhase 1/Phase 2Jan 30, 2018
Details
- Last known activity
- Jun 30, 2021